Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
BMC Research Notes|April 12, 2013
The Hospital de Câncer de Barretos Registry: an analysis of cancer survival at a single institution in Brazil over a 10-year periodEstela Cristina Carneseca, Edmundo Carvalho Mauad, Marcos Aurélio Alves de Araujo, et al.
International Journal of Molecular Sciences|November 27, 2024
Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous MelanomaAna Maria Castro Ferreira, Juliana Carron, Gabriela Vilas Bôas Gomez, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors' Response and Survival in Advanced Melanoma Patients in BrazilBruna Pereira Sorroche, Renan de Jesus Teixeira, Caio Augusto Dantas Pereira, et al.
World Journal of Oncology|November 18, 2017
Analysis of Survival Rates of Patients Diagnosed With Incipient Esophagic CancerEdmundo Carvalho Mauad, Maria do Rosario Dias de Oliveira Latorre, Thiago Buosi Silva, et al.
World Journal of Clinical Oncology|November 16, 2023
Treatment of patients with multiple brain metastases by isolated radiosurgery: Toxicity and survivalAndré Vinícius de Camargo, Marcos Duarte de Mattos, Murilo Kenji Kawasaki, et al.
Revista Brasileira De Epidemiologia = Brazilian Journal of Epidemiology|August 13, 2025
Perspectives on smoking cessation in the oncology environment: insights from brazilian patients and healthcare providersRaquel Descie Veraldi Leite, Ricardo Ribeiro Gama, Fabiana de Lima Vazquez, et al.
Cancers|March 14, 2026
Active Versus Passive Infrared Thermography for Skin Cancer Detection: A Diagnostic Accuracy StudyFernando Malheiros, Evelyn Rocha Silva, Pedro Noronha Fagundes, et al.
International Journal of Molecular Sciences|March 13, 2024
TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous MelanomaBruna Fernandes Carvalho, Gabriela Vilas Bôas Gomez, Juliana Carron, et al.
BMC Research Notes|January 17, 2015
Melanoma characteristics in Brazil: demographics, treatment, and survival analysisVinicius de Lima Vazquez, Thiago Buosi Silva, Marcelo de Andrade Vieira, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 3, 2025
CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survivalBruna Pereira Sorroche, Renan de Jesus Teixeira, Vinicius Gonçalves de Souza, et al.
Pageof 3